DK2132204T3 - Krystalformer af en 8-azabicyclo[3.2.1]octanforbindelse - Google Patents

Krystalformer af en 8-azabicyclo[3.2.1]octanforbindelse

Info

Publication number
DK2132204T3
DK2132204T3 DK08726162.4T DK08726162T DK2132204T3 DK 2132204 T3 DK2132204 T3 DK 2132204T3 DK 08726162 T DK08726162 T DK 08726162T DK 2132204 T3 DK2132204 T3 DK 2132204T3
Authority
DK
Denmark
Prior art keywords
azabicyclo
crystal forms
octane compound
octane
compound
Prior art date
Application number
DK08726162.4T
Other languages
Danish (da)
English (en)
Inventor
Sean Dalziel
Leticia M Preza
Miroslav Rapta
Pierre-Jean Colson
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39620376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2132204(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of DK2132204T3 publication Critical patent/DK2132204T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK08726162.4T 2007-02-28 2008-02-27 Krystalformer af en 8-azabicyclo[3.2.1]octanforbindelse DK2132204T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90409007P 2007-02-28 2007-02-28
PCT/US2008/002583 WO2008106159A1 (en) 2007-02-28 2008-02-27 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

Publications (1)

Publication Number Publication Date
DK2132204T3 true DK2132204T3 (da) 2013-04-29

Family

ID=39620376

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08726162.4T DK2132204T3 (da) 2007-02-28 2008-02-27 Krystalformer af en 8-azabicyclo[3.2.1]octanforbindelse

Country Status (26)

Country Link
US (7) US7943772B2 (https=)
EP (1) EP2132204B1 (https=)
JP (2) JP5512289B2 (https=)
KR (1) KR101480530B1 (https=)
CN (1) CN101616916B (https=)
AR (2) AR065554A1 (https=)
AU (1) AU2008219615B2 (https=)
BR (1) BRPI0807974B8 (https=)
CA (1) CA2678073C (https=)
CL (1) CL2008000573A1 (https=)
CO (1) CO6220856A2 (https=)
CY (1) CY1115077T1 (https=)
DK (1) DK2132204T3 (https=)
ES (1) ES2402031T3 (https=)
HR (1) HRP20130193T1 (https=)
IL (1) IL200131A (https=)
MX (1) MX2009009141A (https=)
MY (1) MY148318A (https=)
NZ (1) NZ578871A (https=)
PL (1) PL2132204T3 (https=)
PT (1) PT2132204E (https=)
RU (1) RU2458061C2 (https=)
SI (1) SI2132204T1 (https=)
TW (1) TWI409067B (https=)
WO (1) WO2008106159A1 (https=)
ZA (1) ZA200905832B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI409067B (zh) 2007-02-28 2013-09-21 Theravance Inc ８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型
TWI415850B (zh) * 2007-07-20 2013-11-21 Theravance Inc 製備ｍｕ類鴉片受體拮抗劑之中間物的方法
ATE502939T1 (de) * 2007-08-27 2011-04-15 Theravance Inc Disubstituierte alkyl-8-azabicycloä3.2.1üoktan- verbindungen als mu-opioid-rezeptorantagonisten
ES2390195T3 (es) * 2007-08-27 2012-11-07 Theravance, Inc. Compuestos de amidoalquil-8-azabiciclo(3,2,1)octano, como antagonistas del receptor opioide mu
TWI423801B (zh) * 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之８－氮雜雙環〔３．２．１〕辛基－２－羥基苯甲醯胺化合物
EP2195313B1 (en) * 2007-08-27 2014-04-02 Theravance, Inc. Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
CA2774021A1 (en) * 2009-09-18 2011-03-24 Adolor Corporation Use of opioid receptor antagonist for gastrointestinal tract disorders
HK1247105A1 (zh) 2015-04-02 2018-09-21 Theravance Biopharma R&D Ip, Llc Mu类鸦片受体拮抗剂与类鸦片药剂的组合剂型

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US6900228B1 (en) * 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
GB9810671D0 (en) * 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
GB9912410D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US6469030B2 (en) * 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
US6467084B1 (en) * 1999-12-16 2002-10-15 Emware, Inc. Systems and methods for reprogramming an embedded device with program code using relocatable program code
IL151550A0 (en) 2000-03-03 2003-04-10 Ortho Mcneil Pharm Inc 3-(diarylmethylene)-8-azabicyclo [3.2.1] octane derivatives
US20020025948A1 (en) * 2000-06-23 2002-02-28 Banks Bernard Joseph 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
EA006708B1 (ru) * 2001-10-22 2006-02-24 Пфайзер Продактс Инк. Производные 3-азабицикло (3.1.0) гексана в качестве антагонистов опиоидного рецептора
US7381721B2 (en) * 2003-03-17 2008-06-03 Adolor Corporation Substituted piperidine compounds
US7056930B2 (en) * 2003-04-14 2006-06-06 Pfizer Inc. 2-Azabicyclo[3.3.1]nonane derivatives
US20040204453A1 (en) * 2003-04-14 2004-10-14 Pfizer Inc 4-Phenyl-piperidine compounds and their use as modulators of opioid receptors
EP1615894A2 (en) * 2003-04-14 2006-01-18 Pfizer Products Inc. 3-azabicyclo 3.2.1 octane derivatives
JP2006523673A (ja) 2003-04-15 2006-10-19 ファイザー・プロダクツ・インク オピオイド受容体活性を有する３−ベンズヒドリリデン−８−アザ−ビシクロ［３．２．１］オクタン誘導体
US6992090B2 (en) * 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use
US7435822B2 (en) 2004-02-03 2008-10-14 Janssen Pharmaceutica N.V. 3-(diheteroarylmethylene)-8-azabicyclo[3.2.1]octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives
US7087749B2 (en) * 2004-03-11 2006-08-08 Adolor Corporation Substituted piperidine compounds and methods of their use
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
AU2007317788B2 (en) 2006-11-07 2013-05-02 Nektar Therapeutics Dosage forms and co-administration of an opioid agonist and an opioid antagonist
TWI409067B (zh) 2007-02-28 2013-09-21 Theravance Inc ８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型

Also Published As

Publication number Publication date
US8816091B2 (en) 2014-08-26
US20080207676A1 (en) 2008-08-28
IL200131A0 (en) 2010-04-15
AR065554A1 (es) 2009-06-17
EP2132204A1 (en) 2009-12-16
CA2678073A1 (en) 2008-09-04
PT2132204E (pt) 2013-03-25
CA2678073C (en) 2016-01-05
KR20090115767A (ko) 2009-11-05
TW200845984A (en) 2008-12-01
SI2132204T1 (sl) 2013-05-31
US9949963B2 (en) 2018-04-24
HK1139399A1 (en) 2010-09-17
RU2458061C2 (ru) 2012-08-10
US20130072515A1 (en) 2013-03-21
CN101616916B (zh) 2011-10-12
EP2132204B1 (en) 2013-01-23
HRP20130193T1 (hr) 2013-03-31
JP5512289B2 (ja) 2014-06-04
KR101480530B1 (ko) 2015-01-08
US20110184008A1 (en) 2011-07-28
TWI409067B (zh) 2013-09-21
NZ578871A (en) 2012-01-12
JP2010520198A (ja) 2010-06-10
MX2009009141A (es) 2009-09-03
CL2008000573A1 (es) 2008-05-16
US8247555B2 (en) 2012-08-21
ZA200905832B (en) 2010-05-26
BRPI0807974B8 (pt) 2021-05-25
US20140080856A1 (en) 2014-03-20
CO6220856A2 (es) 2010-11-19
IL200131A (en) 2013-03-24
US8536335B2 (en) 2013-09-17
RU2009135834A (ru) 2011-04-10
JP2013151564A (ja) 2013-08-08
US10426766B2 (en) 2019-10-01
BRPI0807974B1 (pt) 2020-11-24
US9290491B2 (en) 2016-03-22
CN101616916A (zh) 2009-12-30
ES2402031T3 (es) 2013-04-26
AU2008219615A1 (en) 2008-09-04
US20150073014A1 (en) 2015-03-12
US20180200246A1 (en) 2018-07-19
AU2008219615B2 (en) 2013-05-09
US20160287572A1 (en) 2016-10-06
WO2008106159A1 (en) 2008-09-04
US7943772B2 (en) 2011-05-17
CY1115077T1 (el) 2016-12-14
PL2132204T3 (pl) 2013-06-28
AR109224A2 (es) 2018-11-07
MY148318A (en) 2013-03-29
BRPI0807974A2 (pt) 2014-09-16

Similar Documents

Publication Publication Date Title
LTC2004635I2 (lt) Pakeistieji enaminokarbonilo junginiai
FR18C1017I2 (fr) Composes de glp-1 acyles
UY3776Q (es) Reloj pulsera
EP3450425C0 (en) PERCARBOXYLIC ACID COMPOSITION
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
BRPI0820407A2 (pt) Uso de anticorpos anti-cd40
PL1636190T3 (pl) Trwały kryształ związku 4-oksochinoliny
NO20091286L (no) Krystallfabrikasjon
DK2132204T3 (da) Krystalformer af en 8-azabicyclo[3.2.1]octanforbindelse
DE602008003015D1 (de) Heterocyclische spiroverbindungen
DE602007000609D1 (de) Toner
DE602007002135D1 (de) Kristalloszillator
DE602007011911D1 (de) Stark hydrophober verbundstoff
EP1937650A4 (en) HETEROCYCLIC COMPOUNDS
DK2792662T3 (da) Morphinanforbindelser
DE112007002678A5 (de) Uhrengehäuse
DK2220082T3 (da) Stabilt krystallinsk salt af (R)-3-fluorphenyl-3,4,5-trifluorbenzylcarbaminsyre-1-azabicyclo[2.2.2]oct-3-ylester
ES1066333Y (es) Reloj de pulsera.
DK2121649T3 (da) Fremgangsmåde til fremstilling af benzofuran-2-carboxamider
ATE488416T1 (de) Bob
UA15626S (uk) Наручний годинник
DK1984008T3 (da) Krystal af ACE-N- domæne
SM200800006002S3 (it) Vetri per orologi
FR2918184B1 (fr) Montre-bracelet.
BRMU8502470U (pt) site com categorias de assuntos para navegação instantánea